Dong-A Socio Holdings Co.,Ltd Logo

Dong-A Socio Holdings Co.,Ltd

Holding company with businesses in pharmaceuticals, medical devices, and food/beverages.

000640 | KO

Overview

Corporate Details

ISIN(s):
KR7000640003
LEI:
Country:
South Korea
Address:
서울특별시 동대문구 천호대로 64, 서울특별시

Description

Dong-A Socio Holdings is a holding company that manages a diverse group of businesses centered on healthcare. Its operations span pharmaceuticals, medical devices, food and beverages, and logistics. The group includes key subsidiaries such as Dong-A ST, which focuses on the research and development of ethical drugs, biologics, and innovative new treatments, including AI-based drug discovery. Dong-A Pharmaceutical develops and markets a wide range of over-the-counter healthcare products, consumer goods, and cosmetics. Other specialized affiliates include Dong-A Chammed, providing medical devices and diagnostic solutions, and Aptis, which develops advanced Antibody-Drug Conjugate (ADC) technology. The group also manages popular food and beverage brands.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2022-02-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 38.0 KB
2022-02-04 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 63.6 KB
2022-01-18 00:00
투자판단관련주요경영사항(자회사의 주요경영사항)
Korean HTML 9.9 KB
2022-01-14 00:00
투자유의안내(동아쏘시오홀딩스 2WR의 신주인수권행사기간 만료 및 상장폐지 예고)
Korean HTML 3.9 KB
2022-01-13 00:00
기업설명회(IR)개최(안내공시)
Korean HTML 6.5 KB
2022-01-07 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 60.4 KB
2022-01-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 32.5 KB
2021-12-24 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 293.5 KB
2021-12-23 00:00
[기재정정]신규시설투자등(자회사의 주요경영사항)
Korean HTML 13.2 KB
2021-12-13 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 274.5 KB
2021-12-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 43.4 KB
2021-11-24 00:00
신규시설투자등(자회사의 주요경영사항)
Korean HTML 10.6 KB
2021-11-19 00:00
투자판단관련주요경영사항(자회사의 주요경영사항)
Korean HTML 10.4 KB
2021-11-15 00:00
분기보고서 (2021.09)
Korean HTML 1.3 MB
2021-11-15 00:00
기업설명회(IR)개최(안내공시)
Korean HTML 6.8 KB

Automate Your Workflow. Get a real-time feed of all Dong-A Socio Holdings Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dong-A Socio Holdings Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dong-A Socio Holdings Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.